Kristel Sandra Chatellier is a pharmacist who is specialized in Pharmacotherapy in Pittsburgh, Pennsylvania. Patients can reach her at 1010 Delafield Rd, Pittsburgh or contact her on 866-482-7488. Active license number of Kristel Sandra Chatellier is RP453430 for Pharmacotherapy in Pennsylvania. Kristel Sandra Chatellier is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Kristel Sandra Chatellier speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kristel Sandra Chatellier are as mentioned below.
NPI Number:
1255998100
NPI Enumeration Date:
28 May, 2019
NPI Last Update On:
12 Jun, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kristel Sandra Chatellier are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
RP453430
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1010 Delafield Rd, Pittsburgh, Pennsylvania
Zip:
15240-1005
Phone Number:
--
Fax Number:
--
Patients can reach Kristel Sandra Chatellier at 1010 Delafield Rd, Pittsburgh, Pennsylvania or can call on phone at 866-482-7488.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.